CTL IP Series 2: What is Patent Eligible in the U.S.?
3/19/2021 from 12 pm to 1 pm (EST) For this second virtual meeting of the IP series, Dr. John D. Lop...
3/19/2021 from 12 pm to 1 pm (EST) For this second virtual meeting of the IP series, Dr. John D. Lop...
As part of the Understanding the Rules of Life: Predicting Phenotype, one of ten “Big Ideas” NS...
The Cornell Center for Health Equity is pleased to request applications for one-year pilot project g...
The monthly IBC meetings are open to the public. Please contact cu_ibc@cornell.edu for further infor...
One of the most prestigious awards for early investigators, the National Science Foundation (NSF) F...
Jess Stein, Sr. Licensing & Business Development Officer, will be available to m...
According to Silicon Valley Bank report [1], 28% of U.S. startups have a female founder and 14%...
In 2017, the FDA launched its Digital Health Action Plan with legislation specifically targeting dig...
Join us for a panel discussion on the impacts of COVID-19 on the fruit and vegetable markets across ...
During this third series, Bill Pegg, Associate Director for IP at CTL will be joined by two IP Attor...